Correction to: Diamantopoulos et al., Evaluation of the performance of tuberculin skin test and Quantiferon-TB gold in tube test in patients with hematologic malignancies

This article refers to:

Evaluation of the performance of tuberculin skin test and Quantiferon-TB gold in tube test in patients with hematologic malignancies

Diamantopoulos PT, Tsilimidos GD, Zervakis K, Polonyfi K, Sofotasiou M, Kyrtsonis M-C, Aessopos A, Kyriakakis G and Viniou NA. (2017). Evaluation of the performance of tuberculin skin test and Quantiferon-TB gold in tube test in patients with hematologic malignancies. Infectious Diseases. VOL. 49, NO. 7, pp. 545–548. http://dx.doi.org/10.1080/23744235.2017.1280619.

When the above article was published online, Table 2 was incorrectly labelled.

Incorrect Table 2:

Table 2. Comparison of tuberculin skin test (TST) and Quantiferon TB Gold in Tube test (QFT-GIT) results in 147 patients.

		QFT-GIT			Total
		positive	Negative	Controversial
TST	Positive	122 (83.0)	18 (12.2)	1 (0.7)	141 (95.9)
	Negative	3 (2.0)	2 (1.4)	1 (0.7)	6 (4.1)
Total		125 (85.0)	20 (13.6)	2 (1.4)	147 (100)

Cohen’s kappa = 0.125, p < .047.

The correct table should look like the one below.

Table 2. Comparison of tuberculin skin test (TST) and Quantiferon-TB gold in tube test (QFT-GIT) results in 147 patients.

		QFT-GIT			Total
		Negative	Positive	Controversial
TST	Negative	122 (83.0)	18 (12.2)	1 (0.7)	141 (95.9)
	Positive	3 (2.0)	2 (1.4)	1 (0.7)	6 (4.1)
Total		125 (85.0)	20 (13.6)	2 (1.4)	147 (100)

Cohen’s kappa = 0.125, p < .047.